XML 51 R133.htm IDEA: XBRL DOCUMENT v3.20.1
SHARE-BASED COMPENSATION - Summary (Details)
1 Months Ended 12 Months Ended
Feb. 11, 2019
$ / shares
shares
Feb. 12, 2018
$ / shares
shares
Dec. 31, 2016
shares
Dec. 31, 2019
USD ($)
installment
$ / shares
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Dec. 31, 2017
USD ($)
$ / shares
shares
Dec. 31, 2016
$ / shares
Dec. 31, 2015
Feb. 29, 2020
shares
Dec. 31, 2019
USD ($)
plan
$ / shares
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Number of share-based compensation plans (shares) | plan                   1
Number of shares authorized (shares)                   10,400,000
Award vesting period       5 years            
Share-based compensation expense | $       $ 3,396,000 $ 3,744,000 $ 3,907,000        
Share-based compensation cost capitalized as part of real estate assets | $       $ 66,000 $ 287,000 $ 405,000        
Weighted-Average Grant Date Fair Value                    
Performance period       3 years       3 years    
Vesting rate based on achievement of TSR relative to the NAREIT retail index (as a percent)       33.33%            
Share based Compensation Arrangement by Share based Payment Award Award Vesting Rights Absolute Total Stockholder Return Metrics Percentage       66.66%            
Unrecognized compensation cost related to nonvested stock awards | $                   $ 2,950,000
Compensation cost to be recognized over a weighted-average period       2 years 4 months 24 days            
Shares                    
Performance period       3 years       3 years    
Total fair value of shares earned       0            
Vested each year for the first two anniversaries after conclusion of performance period                    
Weighted-Average Grant Date Fair Value                    
Vesting rate       20.00%            
Subsequent Event                    
Weighted-Average Grant Date Fair Value                    
Number of granted annually shares removed as per amendement                 200,000  
Executive Officer | Maximum                    
Weighted-Average Grant Date Fair Value                    
Percentage released stock awards granted       1.00%            
Restricted Common Stock                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]                    
Nonvested, beginning of period (shares)       875,497            
Granted (shares)       889,811            
Vested (shares)       (780,888)            
Forfeited (shares)       (12,574)            
Nonvested, end of period (shares)       971,846 875,497          
Weighted-Average Grant Date Fair Value                    
Weighted average grant-date fair value, nonvested, beginning of period (USD per share) | $ / shares       $ 7.99            
Weighted average grant-date fair value, granted (USD per share) | $ / shares       2.20 $ 4.55 $ 10.75        
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares       5.16 7.99          
Weighted average grant-date fair value, vested (USD per share) | $ / shares       4.95            
Weighted average grant-date fair value, forfeited (USD per share) | $ / shares       5.87            
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares       5.16 7.99          
Weighted average grant-date fair value, granted (USD per share) | $ / shares       $ 2.20 $ 4.55 $ 10.75        
Total fair value of shares vested | $       $ 3,869,000 $ 2,189,000 $ 2,791,000        
Number of annual installment for awards to vest | installment       4            
Shares                    
Granted (shares)       889,811            
Nonvested, beginning of period (shares)       875,497            
Nonvested, end of period (shares)       971,846 875,497          
Forfeited (shares)       (12,574)            
Weighted average grant-date fair value, forfeited (USD per share) | $ / shares       $ 5.87            
Total fair value of shares vested       780,888            
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | | $ / shares       $ 5.16 $ 7.99         $ 5.16
Granted (shares)       889,811            
Performance Shares                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]                    
Nonvested, beginning of period (shares)       910,911            
Granted (shares)     277,376 1,103,537   741,977        
Vested (shares)       0            
Forfeited (shares)       (108,442)   (247,868)        
Nonvested, end of period (shares)       1,766,580 910,911          
Weighted-Average Grant Date Fair Value                    
Weighted average grant-date fair value, nonvested, beginning of period (USD per share) | $ / shares       $ 4.67            
Weighted average grant-date fair value, granted (USD per share) | $ / shares       2.40   $ 2.63 $ 6.86      
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 4.74 $ 4.76   2.96 $ 4.67          
Weighted average grant-date fair value, forfeited (USD per share) | $ / shares       4.02   6.76        
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares 4.74 4.76   $ 2.96 $ 4.67          
Performance period       3 years            
Weighted average grant-date fair value, granted (USD per share) | $ / shares       $ 2.40   $ 2.63 $ 6.86      
Unrecognized compensation cost related to nonvested stock awards | $                   $ 2,374,000
Shares                    
Granted (shares)     277,376 1,103,537   741,977        
Nonvested, beginning of period (shares)       910,911            
Nonvested, end of period (shares)       1,766,580 910,911          
Forfeited (shares)       (108,442)   (247,868)        
Weighted average grant-date fair value, forfeited (USD per share) | $ / shares       $ 4.02   $ 6.76        
Shares granted in period classified as liabilities (shares)       566,862            
Total fair value of shares vested       0            
Performance period       3 years            
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | | $ / shares $ 4.74 $ 4.76   $ 2.96 $ 4.67         $ 2.96
Risk-free interest rate (as a percent) 2.54% 2.36%                
Expected share price volatility (as a percent) 60.99% 42.02%                
Granted (shares)     277,376 1,103,537   741,977        
Performance Shares | Vested each year for the first two anniversaries after conclusion of performance period                    
Weighted-Average Grant Date Fair Value                    
Vesting rate       20.00%            
Performance Shares | Vested at conclusion of performance period                    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]                    
Share-based compensation expense | $       $ 1,564,000 $ 1,364,000 $ 1,501,000        
Weighted-Average Grant Date Fair Value                    
Vesting rate       60.00%            
Performance Shares | Remaining percentage after performance period                    
Weighted-Average Grant Date Fair Value                    
Compensation cost to be recognized over a weighted-average period       4 years            
Vesting rate       40.00%            
Performance Shares | Chief Executive Officer                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]                    
Granted (shares) 357,800 240,164                
Weighted-Average Grant Date Fair Value                    
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 2.45 $ 3.13                
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 2.45 $ 3.13                
Shares                    
Granted (shares) 357,800 240,164                
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | | $ / shares $ 2.45 $ 3.13                
Granted (shares) 357,800 240,164                
Performance Shares | Officer                    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]                    
Granted (shares) 178,875 120,064                
Weighted-Average Grant Date Fair Value                    
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 2.29 $ 1.63                
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | $ / shares $ 2.29 $ 1.63                
Shares                    
Granted (shares) 178,875 120,064                
Weighted average grant-date fair value, nonvested, ending of period (USD per share) | | $ / shares $ 2.29 $ 1.63                
Granted (shares) 178,875 120,064